Full text is available at the source.
Abstract
Medications like semaglutide and tirzepatide achieve weight-loss outcomes comparable to bariatric surgery.
- FDA-approved antiobesity medications have significantly improved weight-loss outcomes.
- These agents also provide additional health benefits, including improved cardiometabolic health.
- Long-term use of antiobesity medications is necessary to prevent weight regain after discontinuation.
- Ongoing management of overweight and obesity is essential, similar to other chronic diseases.
- Patient education and support are crucial for maintaining weight-loss results.
Simplified